Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

reed’s-(nyse:reed)-receives-new-coverage-from-analysts-at-stocknews.com

Reed’s (NYSE:REED) Receives New Coverage from Analysts at StockNews.com

Jul 28, 2024

Equities research analysts at StockNews.com began coverage on shares of Reed’s (NYSE:REED – Get Free Report) in a…

Read more
analyst-estimates:-here’s-what-brokers-think-of-larsen-&-toubro-limited-(nse:lt)-after-its-first-quarter-report

Analyst Estimates: Here’s What Brokers Think Of Larsen & Toubro Limited (NSE:LT) After Its First-Quarter Report

Jul 28, 2024

The first-quarter results for Larsen & Toubro Limited (NSE:LT) were released last week, making it a good time…

Read more
who-are-nbc’s-olympic-gymnastics-broadcasters?-what-to-know-about-who’s-on-the-call

Who are NBC’s Olympic gymnastics broadcasters? What to know about who’s on the call

Jul 28, 2024

usatoday.com wants to ensure the best experience for all of our readers, so we built our site to…

Read more
fujitsu-limited-beat-analyst-estimates:-see-what-the-consensus-is-forecasting-for-this-year

Fujitsu Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Jul 28, 2024

Fujitsu Limited (TSE:6702) just released its first-quarter report and things are looking bullish. It was overall a positive…

Read more
critical-insights-from-alignment-healthcare-analyst-ratings:-what-you-need-to-know

Critical Insights From Alignment Healthcare Analyst Ratings: What You Need To Know

Jul 26, 2024

In the latest quarter, 4 analysts provided ratings for Alignment Healthcare ALHC, showcasing a mix of bullish and…

Read more
dexcom-faces-short-term-challenges,-but-market-growth-prospects-remain-strong:-analyst

DexCom Faces Short-Term Challenges, But Market Growth Prospects Remain Strong: Analyst

Jul 26, 2024

DexCom Inc DXCM reported second-quarter sales of more than $1 billion. That’s up 15% year-over-year on a reported…

Read more
usana-health-sciences,-inc.-earnings-missed-analyst-estimates:-here’s-what-analysts-are-forecasting-now

USANA Health Sciences, Inc. Earnings Missed Analyst Estimates: Here’s What Analysts Are Forecasting Now

Jul 26, 2024

As you might know, USANA Health Sciences, Inc. (NYSE:USNA) last week released its latest second-quarter, and things did…

Read more
analyst-ratings-for-idexx-laboratories

Analyst Ratings For IDEXX Laboratories

Jul 26, 2024

In the latest quarter, 4 analysts provided ratings for IDEXX Laboratories (NASDAQ:IDXX), showcasing a mix of bullish and…

Read more
cara-therapeutics-(nasdaq:cara)-research-coverage-started-at-stocknews.com

Cara Therapeutics (NASDAQ:CARA) Research Coverage Started at StockNews.com

Jul 25, 2024

Posted by Defense World Staff on Jul 24th, 2024 Stock analysts at StockNews.com started coverage on shares of…

Read more
demystifying-steven-madden:-insights-from-4-analyst-reviews

Demystifying Steven Madden: Insights From 4 Analyst Reviews

Jul 25, 2024

4 analysts have expressed a variety of opinions on Steven Madden (NASDAQ:SHOO) over the past quarter, offering a…

Read more
brooklyn-immunotherapeutics-(nyse:btx)-coverage-initiated-by-analysts-at-stocknews.com

Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated by Analysts at StockNews.com

Jul 25, 2024

Equities research analysts at StockNews.com began coverage on shares of Brooklyn ImmunoTherapeutics (NYSE:BTX – Get Free Report) in…

Read more
cellectis-(nasdaq:clls)-research-coverage-started-at-stocknews.com

Cellectis (NASDAQ:CLLS) Research Coverage Started at StockNews.com

Jul 25, 2024

Posted by Defense World Staff on Jul 24th, 2024 Stock analysts at StockNews.com assumed coverage on shares of…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 296
  6. 297
  7. 298
  8. 299
  9. 300
  10. 301
  11. 302
  12. ...
  13. 381
  14. »

Posts pagination

Newer posts Page 1 … Page 299 … Page 381 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.